News | December 15, 2022
China aims to lead next bio revolution in advanced biologics, says GlobalData
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
Desonide Cream, 0.05%, has an estimated market size of US $12 million for twelve months ending Sep 2022 according to IQVIA
Asia’s premier and USA-patented, ANSSI Wellness for spinal decompression was launched in Pune
Diclofenac Sodium Topical Solution USP, 2% w/w has an estimated market size of US $512 million for twelve months ending Sep 2022 according to IQVIA
The inspection of the facility resulted in issuance of a Form-483 with eight observations each for the Drug Product facility and API facility at the site
Nifedipine Extended-Release Tablets have an estimated market size of US $56 million for twelve months ending September 2022
Doxycycline Capsules (RLD Oracea) had estimated annual sales of US $215 million in the US
Drospirenone Tablets (RLD Slynd) had estimated annual sales of US $141 million in the US
API platform to comprise of RA Chem Pharma, ZCL Chemicals and Avra Laboratories
The company is committed to addressing the observations at the earliest, and gaining approval for injectable manufacturing for the US
Subscribe To Our Newsletter & Stay Updated
